Holdings of Eaton Vance Worldwide Health Sciences Fund
Eaton Vance Growth Trust · 43 declared positions · as of Feb 28, 2026
Original filing · Net assets 858M $ · Ten largest lines: 55.9 % of the equity sleeve
Sector breakdown
- Health care 79.3 %
- Unattributed 20.7 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 75.5 %
- CHF 10.2 %
- GBP 6.6 %
- EUR 4.3 %
- DKK 1.8 %
- AUD 1.6 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 73.3 %
- CH 10.2 %
- GB 6.6 %
- FR 3.2 %
- NL 1.9 %
- DK 1.8 %
- AU 1.6 %
- IT 1.0 %
- CA 0.3 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 28 | 627M $ | 73.32 % |
| CH | 4 | 87.3M $ | 10.21 % |
| GB | 1 | 56.2M $ | 6.57 % |
| FR | 2 | 27.7M $ | 3.24 % |
| NL | 2 | 16.3M $ | 1.91 % |
| DK | 2 | 15.6M $ | 1.83 % |
| AU | 1 | 14M $ | 1.64 % |
| IT | 2 | 8.7M $ | 1.02 % |
| CA | 1 | 2.2M $ | 0.26 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Eli Lilly & Co | 92,406 | 97.2M $ | 11.33 % |
| AbbVie Inc | 246,272 | 57.2M $ | 6.66 % |
| AstraZeneca PLC | 266,858 | 56.2M $ | 6.54 % |
| Johnson & Johnson | 216,808 | 53.9M $ | 6.28 % |
| Roche Holding AG | 105,518 | 50.2M $ | 5.85 % |
| Merck & Co Inc | 307,185 | 38M $ | 4.43 % |
| Bristol-Myers Squibb Co | 563,654 | 35.2M $ | 4.10 % |
| UnitedHealth Group Inc | 109,349 | 32.1M $ | 3.74 % |
| Vertex Pharmaceuticals Inc | 60,680 | 30.1M $ | 3.51 % |
| Gilead Sciences Inc | 188,375 | 28.1M $ | 3.27 % |
| Abbott Laboratories | 236,553 | 27.5M $ | 3.21 % |
| Zoetis Inc | 200,609 | 26.3M $ | 3.07 % |
| Sanofi SA | 254,833 | 24.9M $ | 2.90 % |
| Thermo Fisher Scientific Inc | 47,190 | 24.6M $ | 2.87 % |
| Intuitive Surgical Inc | 48,480 | 24.4M $ | 2.84 % |
| Boston Scientific Corp | 294,341 | 22.6M $ | 2.64 % |
| Stryker Corp | 54,948 | 21.3M $ | 2.48 % |
| Medtronic PLC | 185,134 | 18.1M $ | 2.11 % |
| Lonza Group AG | 21,984 | 15.3M $ | 1.78 % |
| CSL Ltd | 134,162 | 14M $ | 1.64 % |
| Argenx SE | 17,543 | 13.5M $ | 1.57 % |
| Edwards Lifesciences Corp | 146,286 | 12.6M $ | 1.47 % |
| Mettler-Toledo International Inc | 8,731 | 11.9M $ | 1.39 % |
| Novartis AG | 70,029 | 11.8M $ | 1.37 % |
| Cooper Cos Inc/The | 128,221 | 10.7M $ | 1.25 % |
| Novo Nordisk A/S | 283,516 | 10.7M $ | 1.25 % |
| Straumann Holding AG | 83,976 | 10.1M $ | 1.17 % |
| Royalty Pharma PLC | 215,358 | 10M $ | 1.16 % |
| Danaher Corp | 37,052 | 7.8M $ | 0.91 % |
| Neurocrine Biosciences Inc | 51,654 | 6.8M $ | 0.80 % |
| McKesson Corp | 6,322 | 6.2M $ | 0.73 % |
| Bio-Techne Corp | 100,598 | 5.9M $ | 0.69 % |
| Option Care Health Inc | 178,995 | 5.8M $ | 0.68 % |
| Recordati Industria Chimica e Farmaceutica SpA | 91,672 | 5.2M $ | 0.61 % |
| HeartFlow Inc | 218,978 | 5.1M $ | 0.59 % |
| Genmab A/S | 16,690 | 4.9M $ | 0.57 % |
| Amplifon SpA | 225,283 | 3.5M $ | 0.41 % |
| Newamsterdam Pharma Co NV | 81,652 | 2.9M $ | 0.34 % |
| EssilorLuxottica SA | 10,648 | 2.8M $ | 0.33 % |
| Caris Life Sciences Inc | 135,807 | 2.7M $ | 0.32 % |
| CENTESSA PHARMACEUTICALS PLC | 91,966 | 2.5M $ | 0.29 % |
| Apogee Therapeutics Inc | 33,655 | 2.4M $ | 0.27 % |
| Xenon Pharmaceuticals Inc | 51,377 | 2.2M $ | 0.26 % |